Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Bayir is a global manufacturer and supplier specializing in nutraceutical ingredients, botanical extracts, and pharmaceutical active ingredients. Established in 1985, the company is recognized as one of the world's largest producers of glucosamine and a key supplier of chondroitin and specialized herbal extracts like Coleus forskohlii and Garcinia cambogia. With multiple GMP-certified manufacturing units in India and a dedicated distribution hub in the United States, Bayir serves the global dietary supplement and pharmaceutical sectors. The company emphasizes quality control and vertical integration to ensure the purity and efficacy of its health-focused ingredients. Its product portfolio supports various therapeutic areas, including joint health, weight management, and cognitive wellness.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Bayir.